Indications and uses
For preparation of the skin prior to injection or venipuncture
For preparation of the skin prior to injection or venipuncture
start at the venipuncture site and apply in a circular fashion use additional wipes as necessary to cover area
Drug Facts
Isopropyl Alcohol 71.5%
Antiseptic
For external use only
Flammable. Keep away from fire or flame
Do not use with electrocautery procedures or in or near the eyes. If this happens, rinse thoroughly with water.
Stop use and ask doctor if irritation or redness develop and persists for more than 72 hours
Keep out of reach of children If swallowed get medical help or contact a Poison Control Center right away
purified/deionized water, ethyl ester of PVMA/MA copolymer, ethyl alcohol, acetyl tributyl citrate, chloroxylenol
Safetec
I.V. Prep
Antiseptic/Barrier Wipe
For preparation of the skin prior to injection or venipuncture
Contents: 1 single-use, premoistened towelette
Manufactured by SAFETEC OF AMERICA, Inc.
Buffalo, NY 14215 800-456-7077
www.safetec.com

| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6c13b22c-b3ba-4127-b768-0132dd5ab0d1 | Product name | 1 | 20230829 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 61010-7000-1 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-0373-f424-e053-dadaa90a57ce | 4a0a404e-dfba-4df0-bc04-59a87502265b |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61010-7000-0 | Antiseptic | 0.0012 L in 1 PACKET | LIQUID | 0.0012 | 4 | |
| 61010-7000-1 | Antiseptic | 50 in 1 BOX | LIQUID | 50 | 4 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 61010-7000 | ANTISEPTIC (ISOPROPYL ALCOHOL) LIQUID [SAFETEC OF AMERICA] | 4 | Legacy NDC, 2 package rows | 20110617_4a0a404e-dfba-4df0-bc04-59a87502265b.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| isopropyl alcohol | ACTIVE INGREDIENT | ND2M416302 | 4 | |
| isopropyl alcohol | ACTIVE MOIETY | ND2M416302 | 4 | |
| acetyltributyl citrate | INACTIVE INGREDIENT | 0ZBX0N59RZ | 4 | |
| alcohol | INACTIVE INGREDIENT | 3K9958V90M | 4 | |
| chloroxylenol | INACTIVE INGREDIENT | 0F32U78V2Q | 4 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 61010-7000 | 61010-7000-0, 61010-7000-1 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| isopropyl alcohol | ND2M416302 | ACTIB |
| water | 059QF0KO0R | IACT |
| alcohol | 3K9958V90M | IACT |
| acetyltributyl citrate | 0ZBX0N59RZ | IACT |
| chloroxylenol | 0F32U78V2Q | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| acetyltributyl citrate | ACETYLTRIBUTYL CITRATE | 0ZBX0N59RZ | CAPSULE, EXTENDED RELEASE / ORAL | 23 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| acetyltributyl citrate | ACETYLTRIBUTYL CITRATE | 0ZBX0N59RZ | CAPSULE, COATED / ORAL | 11 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| acetyltributyl citrate | ACETYLTRIBUTYL CITRATE | 0ZBX0N59RZ | SOLUTION / TOPICAL | 5.4 %w/w | ||
| acetyltributyl citrate | ACETYLTRIBUTYL CITRATE | 0ZBX0N59RZ | CAPSULE, DELAYED RELEASE / ORAL | 122 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| acetyltributyl citrate | ACETYLTRIBUTYL CITRATE | 0ZBX0N59RZ | CAPSULE / ORAL | 7 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| chloroxylenol | CHLOROXYLENOL | 0F32U78V2Q | SOLUTION / AURICULAR (OTIC) | 0.1 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| acetyltributyl citrate | ACETYLTRIBUTYL CITRATE | 0ZBX0N59RZ | TABLET, DELAYED RELEASE / ORAL | 69 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| chloroxylenol | CHLOROXYLENOL | 0F32U78V2Q | CREAM / TOPICAL | 0.15 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| acetyltributyl citrate | ACETYLTRIBUTYL CITRATE | 0ZBX0N59RZ | TABLET / ORAL | 150 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| acetyltributyl citrate | ACETYLTRIBUTYL CITRATE | 0ZBX0N59RZ | TABLET, EXTENDED RELEASE / ORAL | 309 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 188fff36-2829-4077-8115-bb90e0c25bbb | 4a0a404e-dfba-4df0-bc04-59a87502265b | 2011-06-09 | Warnings | 188fff36-2829-4077-8115-bb90e0c25bbb 4a0a404e-dfba-4df0-bc04-59a87502265b |
Adverse event summaries are temporarily unavailable. Other product information remains available.